NCT02736032View on ClinicalTrials.gov

Cryopreserved-thawed Embryo Transfer With or Without Gonadotropin Releasing Hormone Agonist

PHASE3CompletedINTERVENTIONAL
Enrollment

310

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

May 31, 2018

Study Completion Date

May 31, 2018

Conditions
Infertility
Interventions
PROCEDURE

Embryo transfer

The transfer of cryopreserved-thawed embryos inside the uterus aiming to achieve pregnancy

PROCEDURE

Serum Estradiol and Progesterone levels

Serum estradiol and serum progesterone levels in blood on the day of start of progesterone supplementation

DRUG

GnRH agonist

GnRH agonist given on day 21 of the cycle preceding the embryo transfer

DRUG

External Estradiol

Estradiol started on day1 of the cycle for endometrial prepartaion

DRUG

Progesterone

progesterone as luteal phase support start after endometrium is well prepared

Trial Locations (3)

12411

IVF centre, Obstetrics and Gynaecology Department, Cairo University Hospitals (Kasr EL Aini), Cairo

Kamal Shaeer center of infertility, Giza

Nile IVF center, Giza

All Listed Sponsors
collaborator

Nile Ivf Center, Cairo, Egypt

OTHER

collaborator

Kamal Shaeer center of infertility

UNKNOWN

lead

Cairo University

OTHER

NCT02736032 - Cryopreserved-thawed Embryo Transfer With or Without Gonadotropin Releasing Hormone Agonist | Biotech Hunter | Biotech Hunter